The Ascelia’s auditor is appointed by the annual general meeting for the period until the end of the next annual general meeting. The auditor examines the annual report and accounts as well as the management performed by the board of directors and the CEO. Following each financial year, the auditor shall submit an audit report to the annual general meeting. The Ascelia’s auditor reports its observations from the audit and its assessment of the Ascelia’s internal control to the board of directors.
At the Extraordinary General Meeting held on 26 April 2018, ÖhrlingsPricewaterhouse Coopers AB was elected as Ascelia Pharma’s auditor for the time period up until the next annual shareholders’ meeting. ÖhrlingsPricewaterhouse Coopers AB is represented by Carl Fogelberg who holds the main responsibility for the audit of Ascelia Pharma.